UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  April 3, 2006

                            BIOLOK INTERNATIONAL INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

DELAWARE                             000-51482                 65-0317138
--------------------------------------------------------------------------------
(State or other jurisdiction        (Commission              (IRS Employer
Of incorporation)                   File Number)          Identification Number)

                              368 S. Military Trail
                            Deerfield Beach, FL 33442
--------------------------------------------------------------------------------
                    (Address of Principal Executive Offices)

                                 (954) 698-9998
--------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)

                                      None
--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:

|_|   Writt ten communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)
|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)
|_|   Pre-commencement  communications  pursuant  to  Rule  14d-2(b)  under  the
      Exchange Act (17 CFR 240.14d-2(b))
|_|   Pre-commencement  communications  pursuant  to  Rule  13e-4(c)  under  the
      Exchange Act (17 CFR 240.13e-4(c))


<PAGE>

Item 8.01        Other Events

Commencing  April 3, 2006,  BioLok  International  Inc. (the "Company")  (OTCBB:
BLLI)  and  its  President  and  CEO,  Bruce  L.  Hollander,  made a  number  of
presentations to the investment  community on the current status of the Company.
A copy of the power point presentation is attached as Exhibit 99.1.

The  information  under  this  caption,  "Item 8.01 - Other  Events,"  including
information in any related  exhibits,  is being  furnished to the Securities and
Exchange  Commission  and shall not be deemed "filed" for purposes of Section 18
of the  Securities  Exchange Act of 1934, as amended (the  "Exchange  Act"),  or
otherwise subject to the liabilities of the Section.  This information shall not
be deemed  incorporated  by reference in any filing under the  Securities Act of
1933, as amended, or the Exchange Act, except as expressly set forth by specific
reference in such a filing.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

      (d) Exhibits

Exhibit No.                Description
--------------------------------------------------------------------------------
99.1                       Power Point presentation Dated April 3, 2006.


<PAGE>


                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Dated: March 29, 2006                        /s/ Bruce L. Hollander
                                         ---------------------------------------
                                         Bruce L. Hollander, President
{"company-data": {"conformed-name": "BIO LOK INTERNATIONAL INC", "cik": "0000840573", "assigned-sic": "3843", "irs-number": "630317138", "state-of-incorporation": "DE", "fiscal-year-end": "1031"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51482", "film-number": "06738726"}, "business-address": {"street1": "312 S MILITARY TRAIL", "city": "DEERFIELD BEACH", "state": "FL", "zip": "33442", "phone": "9546989998"}, "mail-address": {"street1": "312 S MILITARY TRAIL", "city": "DEERFIELD BEACH", "state": "FL", "zip": "33442"}, "former-company": [{"former-conformed-name": "AMERICAN BIODENTAL CORP", "date-changed": "19950609"}, {"former-conformed-name": "MINIMATIC IMPLANT TECHNOLOGY INC", "date-changed": "19950609"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  April 3, 2006

                            BIOLOK INTERNATIONAL INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

DELAWARE                             000-51482                 65-0317138
--------------------------------------------------------------------------------
(State or other jurisdiction        (Commission              (IRS Employer
Of incorporation)                   File Number)          Identification Number)

                              368 S. Military Trail
                            Deerfield Beach, FL 33442
--------------------------------------------------------------------------------
                    (Address of Principal Executive Offices)

                                 (954) 698-9998
--------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)

                                      None
--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:

|_|   Writt ten communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)
|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)
|_|   Pre-commencement  communications  pursuant  to  Rule  14d-2(b)  under  the
      Exchange Act (17 CFR 240.14d-2(b))
|_|   Pre-commencement  communications  pursuant  to  Rule  13e-4(c)  under  the
      Exchange Act (17 CFR 240.13e-4(c))
Item 8.01        Other Events

Commencing  April 3, 2006,  BioLok  International  Inc. (the "Company")  (OTCBB:
BLLI)  and  its  President  and  CEO,  Bruce  L.  Hollander,  made a  number  of
presentations to the investment  community on the current status of the Company.
A copy of the power point presentation is attached as Exhibit 99.1.

The  information  under  this  caption,  "Item 8.01 - Other  Events,"  including
information in any related  exhibits,  is being  furnished to the Securities and
Exchange  Commission  and shall not be deemed "filed" for purposes of Section 18
of the  Securities  Exchange Act of 1934, as amended (the  "Exchange  Act"),  or
otherwise subject to the liabilities of the Section.  This information shall not
be deemed  incorporated  by reference in any filing under the  Securities Act of
1933, as amended, or the Exchange Act, except as expressly set forth by specific
reference in such a filing.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

      (d) Exhibits

Exhibit No.                Description
--------------------------------------------------------------------------------
99.1                       Power Point presentation Dated April 3, 2006.
SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Dated: March 29, 2006                        /s/ Bruce L. Hollander
                                         ---------------------------------------
                                         Bruce L. Hollander, President